Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:10:28.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with a generic access notice.
    Difference
    19%
    Check dated 2026-09-19T19:25:16.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The footer revision label updated from v3.6.5 to v3.6.6, signaling a small version update. There are no changes to the study content or navigation elements.
    Difference
    0.1%
    Check dated 2026-08-29T22:11:19.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a new revision of the study record has been published.
    Difference
    0.1%
    Check dated 2026-08-08T20:54:53.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page revision is updated from v3.6.3 to v3.6.4, indicating a new version of the page template. This reflects an internal update to the page structure rather than content changes.
    Difference
    0.1%
    Check dated 2026-07-25T13:20:16.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a newer version of the page. This appears to reflect minor edits without altering study data or its presentation.
    Difference
    0.1%
    Check dated 2026-07-04T04:13:37.000Z thumbnail image

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.